Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,043 | -4,687 | N/A | -11,845 | -8,640 |
| Depreciation Amortization | 164 | 102 | N/A | 462 | 310 |
| Accounts receivable | N/A | N/A | N/A | -201 | -181 |
| Accounts payable and accrued liabilities | 174 | 263 | N/A | 128 | 395 |
| Other Working Capital | 177 | -505 | N/A | -831 | -1,139 |
| Other Operating Activity | -461 | -614 | 0 | -2,990 | -1,866 |
| Operating Cash Flow | $-8,989 | $-5,441 | $N/A | $-15,277 | $-11,121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | N/A | N/A | -32 | -32 |
| Investing Cash Flow | $-19 | $N/A | $N/A | $-32 | $-32 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 48 | 48 |
| Common Stock Repurchased | 10 | 10 | N/A | 15 | 10 |
| Other Financing Activity | 2,163 | 569 | 0 | -55 | 0 |
| Financing Cash Flow | $2,173 | $579 | $N/A | $8 | $58 |
| Beginning Cash Position | 24,588 | 24,588 | N/A | 39,781 | 39,781 |
| End Cash Position | 17,753 | 19,726 | N/A | 24,480 | 28,686 |
| Net Cash Flow | $-6,835 | $-4,862 | $N/A | $-15,301 | $-11,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,989 | -5,441 | N/A | -15,277 | -11,121 |
| Capital Expenditure | -19 | N/A | N/A | -32 | -32 |
| Free Cash Flow | -9,008 | -5,441 | 0 | -15,309 | -11,153 |